efatutazone dihydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-013217
The dihydrochloride salt of efatutazone, an orally bioavailable agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma) with potential antineoplastic activity. Efatutazone binds to and activates PPAR-gamma, a nuclear hormone receptor and a ligand-activated transcription factor controling gene expression involved in macromolecule metabolism and cell differentiation, specifically adipocyte differentiation. Mediated through activation of PPAR-gamma, this agent is capable of inducing cell differentiation and apoptosis, thereby leading to a reduction in cellular proliferation.
| Identifier | MLC-T-ONC-013217 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | PPAR-gamma agonist CS-7017; inolitazone dihydrochloride |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013217",
"term": "efatutazone dihydrochloride",
"field": "Oncology and biomedicine",
"definition": "The dihydrochloride salt of efatutazone, an orally bioavailable agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma) with potential antineoplastic activity. Efatutazone binds to and activates PPAR-gamma, a nuclear hormone receptor and a ligand-activated transcription factor controling gene expression involved in macromolecule metabolism and cell differentiation, specifically adipocyte differentiation. Mediated through activation of PPAR-gamma, this agent is capable of inducing cell differentiation and apoptosis, thereby leading to a reduction in cellular proliferation.",
"synonyms": [
"PPAR-gamma agonist CS-7017",
"inolitazone dihydrochloride"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/efatutazone-dihydrochloride/"
}
Record 6,392 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.